The objectives of the present analyses were to assess the association
between HbA(1c) levels and severe hypoglycaemia (SH, treatment with gl
ucose i.v. or glucagon injection) and to identify predictors of SH in
a prospective multicentre trial. The study population consisted of 636
insulin-dependent diabetic patients who had participated in a structu
red 5-day in-patient group treatment and teaching programme for intens
ification of insulin therapy (ITTP) in one of 10 hospitals and who wer
e re-examined after 1, 2, 3, and 6 years including assessment of demog
raphic, disease and treatment related parameters, diabetes-related kno
wledge, behaviour, and emotional coping. At baseline, age (mean +/- SD
) was 27 +/- 7 years, diabetes duration 9 +/- 7 years and HbA(1c) 8.3
+/- 1.9%. During the 6-year follow-up, the mean HbA(1c) value improved
to 7.6%, and in patients with a diabetes duration of more than 1 year
at entry into the study (n = 538) the incidence of SH decreased from
0.28 cases/patient/year during the year preceding the ITTP to 0.17 cas
es/patient/year. The patient group was divided into decile groups acco
rding to mean follow-up HbA(1c) values. In each group more than 230 pa
tient years could be analysed. Groups with mean HbA(1c) values of 5.7,
7.0, 7.4, 7.7 and 8.9% had comparable risks of SH (0.15-0.19 cases/ p
atient/year). In a logistic regression analysis, mean HbA(1c) during f
ollow-up, a history of SH during the year preceding the ITTP, C-peptid
e level, emotional coping, carrying emergency carbohydrates (as assess
ed at the 1-year follow-up), and age at onset of diabetes were signifi
cant independent predictors of SH. The incidence of SH between centres
varied between 0.05 and 0.27 cases/patient/year. In conclusion, in th
e present analyses no linear or exponential relationship between HbA(1
c) and severe hypoglycaemia could be identified by using simple group
comparisons. Applying complex regression analyses, various patient-rel
ated predictors of severe hypoglycaemia were identified.